Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1209 visite)

Fondo Europeo Pesca
(622 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1094 visite)

 INMiND
(1186 visite)

Instruct-IT
(Link esterno)

 PRIN
(1329 visite)

 eHealthNet
(1090 visite)

Ponrec
(1028 visite)

MFAG Grant
(1134 visite)

MERIT
(Link esterno)


Collegamenti

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (153 visite)

Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V

Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.



Tipo di articolo: Journal Article, Review,

Impact factor: 2.659, Impact factor a 5 anni: 2.875

Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84865741390&partnerID=40&md5=c7b9926e5227d58c39c3435d44a0c0a1

Parole chiave: Brain Ischemia, Chronic Neurodegenerative Disorders, Metabotropic Glutamate Receptors, Neuroprotection, Neurotrophic Factors, 6 Tetrahydro 1 Methyl 4 Phenylpyridine, 2 Methyl 6 (phenylethynyl)pyridine, 3 [(2 Methyl 4 Thiazolyl)ethynyl]pyridine, 4 Amino 2 Oxabicyclo[3.1.0]hexane 4, 6 Dicarboxylic Acid, Brain Derived Neurotrophic Factor, Levodopa, Metabotropic Receptor, Metabotropic Receptor Antagonist, N Phenyl 7 (hydroxyimino)cyclopropa[b]chromen 1a Carboxamide, Nerve Growth Factor, Neurite Promoting Factor, Transforming Growth Factor Beta, Unclassified Drug, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Article, Brain Damage, Dopaminergic Nerve Cell, Dyskinesia, Excitotoxicity, Human, Intoxication, Learning Disorder, Nerve Cell Lesion, Nerve Cell Necrosis, Nerve Degeneration, Neurotoxicity, Nigroneostriatal System, Nonhuman, Parkinson Disease, Priority Journal, Striatonigral Degeneration, Stroke, Allosteric Regulation, Animals, Haplorhini, Neuroprotective Agents, Neuroprotective Agents Pharmacology, Metabotropic Glutamate Metabolism, 2 Methyl 6 (phenylethynyl) Pyridine, 3 [(2 Methyl 4 Thiazolyl) Ethynyl] Pyridine, 4 Amino 2 Oxabicyclo [3. 1. 0] Hexane 4, N Phenyl 7 (hydroxyimino) Cyclopropa [b] Chromen 1a Carboxamide,

Affiliazioni:

*** IBB - CNR ***
Department of Formative Processes, University of Catania, Catania, Italy
Department of Clinical and Molecular Biomedicine, Section of Pharmacology, University of Catania, Catania 95125, Italy
I.N.M. Neuromed, Località Camerelle, 86077 Pozzilli, Italy
Department of Drug Sciences, University of Catania, Catania, Italy
I.B.B., CNR-Catania, 95125 Catania, Italy
Department of Human Physiology and Pharmacology, University of Rome, Sapienza, Piazzale Aldo Moro, 5, 00185 Rome, Italy
I. N. M. Neuromed, Localit Camerelle, 86077 Pozzilli, Italy
I. B. B., CNR-Catania, 95125 Catania, Italy



Riferimenti:

Albers, G.W., Goldberg, M.P., Choi, D.W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40

Ambrosini, A., Bresciani, L., Fracchia, S., Brunello, N., Racagni, G., Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-d-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro (1995) Mol. Pharmacol., 47, pp. 1057-1064

Armentero, M.T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9

Aronica, E., Catania, M.V., Geurts, J., Yankaya, B., Troost, D., Immunohistochemical localization of group i and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: Upregulation in reactive astrocytes (2001) Neuroscience, 105, pp. 509-520

Aronica, E., Gorter, J.A., Ijlst-Keizers, H., Rozemuller, A.J., Yankaya, B., Leenstra, S., Troost, D., Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins (2003) Eur. J. Neurosci., 17, pp. 2106-2118

Attucci, S., Carlà, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806

Balázs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C.W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163

Battaglia, G., Bruno, V., Ngomba, R.T., Di Grezia, R., Copani, A., Nicoletti, F., Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death (1998) Eur. J. Pharmacol., 356, pp. 271-274

Battaglia, G., Busceti, C.L., Molinaro, G., Biagioni, F., Storto, M., Fornai, F., Nicoletti, F., Bruno, V., Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (2004) J. Neurosci., 24, pp. 828-835

Battaglia, G., Molinaro, G., Riozzi, B., Storto, M., Busceti, C.L., Spinsanti, P., Bucci, D., Bruno, V., Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons (2009) PLoS One, 4 (8), p. 6591

Battaglia, G., Cannella, M., Riozzi, B., Orobello, S., Maat-Schieman, M.L., Aronica, E., Busceti, C.L., Squitieri, F., Early defect of transforming growth factor beta-1 formation in Huntington's disease (2010) J. Cell Mol. Med., 15, pp. 551-557

Battaglia, G., Riozzi, B., Molinaro, G., Bucci, D., Storto, M., Pallottino, M., Nicoletti, F., Bruno, V., Group-II mGluRs as drug targets in the treatment of amyotrophic lateral sclerosis (2011) Curr. Neuropharmacol., 9 (S1), p. 3

Berg, D., Godau, J., Trenkwalder, C., Eggert, K., Csoti, I., Storch, A., Huber, H., Gomez-Mancilla, B., AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials (2011) Mov. Disord., 26, pp. 1243-1250

Black, Y.D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A.L., Schwarzschild, M.A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165

Bond, A., O'Neill, M.J., Hicks, C.A., Monn, J.A., Lodge, D., Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia (1998) Neuroreport, 9, pp. 1191-1193

Bond, A., Ragumoorthy, N., Monn, J.A., Hicks, C.A., Ward, M.A., Lodge, D., O'Neill, M.J., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia (1999) Neurosci. Lett., 273, pp. 191-194

Bond, A., Jones, N.M., Hicks, C.A., Whiffin, G.M., Ward, M.A., O'Neill, M.F., Kingston, A.E., O'Neill, M.J., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo (2000) J. Pharmacol. Exp. Ther., 294, pp. 800-809

Brakeman, P.R., Lanahan, A.A., O'Brien, R., Roche, K., Barnes, C.A., Huganir, R.L., Worley, P.F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288

Brazil, D.P., Hemmings, B.A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664

Bruno, V., Copani, A., Battaglia, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death (1994) Eur. J. Pharmacol., 256, pp. 109-112

Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Activation of class II or class III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration (1995) Eur. J. Neurosci., 7, pp. 1906-1913

Bruno, V., Sureda, F.X., Storto, M., Casabona, G., Caruso, A., Knopfel, T., Kuhn, R., Nicoletti, F., The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling (1997) J. Neurosci., 17, pp. 1891-1897

Buisson, A., Choi, D.W., The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death (1995) Neuropharmacology, 34, pp. 1081-1087

Caraci, F., Molinaro, G., Battaglia, G., Giuffrida, M.L., Riozzi, B., Traficante, A., Bruno, V., Nicoletti, F., Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: Selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (2011) Mol. Pharmacol., 79, pp. 618-626

Caraci, F., Spampinato, S., Sortino, M.A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Copani, A., Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (2011) Cell Tissue Res., , 10.1007/s00441-011-1230-6

Caraci, F., Bosco, P., Signorelli, M., Spada R., .S., Cosentino F., .I., Toscano, G., Bonforte, C., Ferri, R., The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression (2011) Eur. Neuropsychopharmacol., , doi:10.1016/j.euroneuro.2011.08.006

Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634

Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., Nicoletti, F., Caciagli, F., Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes (1999) Glia, 27, pp. 275-281

Cippitelli, A., Damadzic, R., Frankola, K., Goldstein, A., Thorsell, A., Singley, E., Eskay, R.L., Heilig, M., Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: Prevention by group II metabotropic glutamate receptor activation (2010) Biol. Psychiatry, 67, pp. 823-830

Conn, P.J., Battaglia, G., Marino, M.J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798

Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., Nicoletti, F., Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide (1995) Mol. Pharmacol., 47, pp. 890-897

Copani, A., Guccione, S., Giurato, L., Caraci, F., Calafiore, M., Sortino, M.A., Nicoletti, F., The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (2008) Curr. Med. Chem., 15, pp. 2420-2432

Corti, C., Battaglia, G., Molinaro, G., Riozzi, B., Pittaluga, A., Corsi, M., Mugnaini, M., Bruno, V., The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/ neuroprotection (2007) J. Neurosci., 27, pp. 8297-8308

Cozzi, A., Meli, E., Carlà, V., Pellicciari, R., Moroni, F., Pellegrini-Giampietro, D.E., Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity? (2002) Neuropharmacology, 43, pp. 119-130

D'Antoni, S., Berretta, A., Seminara, G., Longone, P., Giuffrida-Stella, A.M., Battaglia, G., Sortino, M.A., Catania, M.V., A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death (2011) Neurobiol. Dis., 42, pp. 252-264

De Vry, J., Horváth, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214

Di Liberto, V., Bonomo, A., Frinchi, M., Belluardo, N., Mudò, G., Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain (2010) Neuroscience, 165, pp. 863-873

Doherty, A.J., Palmer, M.J., Henley, J.M., Collingridge, G.L., Jane, D.E., (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267

D'Onofrio, M., Cuomo, L., Battaglia, G., Ngomba, R.T., Storto, M., Kingston, A.E., Orzi, F., Bruno, V., Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways (2001) J. Neurochem., 78, pp. 435-445

Duty, S., Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease (2010) Br. J. Pharmacol., 161, pp. 271-287

Emery, A.C., Pshenichkin, S., Takoudjou, G.R., Grajkowska, E., Wolfe, B.B., Wroblewski, J.T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, β-Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048

Emery A., .C., Hathaway, H., Pshenichkin, S., Takoudjou G., .R., Diraddo, J., Grajkowska, E., Yasuda R., .P., Wroblewski J., .T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18

Engers, D.W., Field, J.R., Le, U., Zhou, Y., Bolinger, J.D., Zamorano, R., Blobaum, A.L., Hopkins, C.R., Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110

Ferraguti, F., Shigemoto, R., Metabotropic glutamate receptors (2006) Cell Tissue Res., 326, pp. 483-504

Gasparini, F., Bruno, V., Battaglia, G., Lukic, S., Leonhardt, T., Inderbitzin, W., Laurie, D., Flor, P.J., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo (1999) J. Pharmacol. Exp. Ther., 289, pp. 1678-1687

Gill, S.S., Patel, N.K., Hotton, G.R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D.J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595

Hardingham, G.E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696

Henrich-Noack, P., Hatton, C.D., Reymann, K.G., The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils (1998) Neuroreport, 9, pp. 985-988

Henrich-Noack, P., Flor, P.J., Sabelhaus, C.F., Prass, K., Dirnagl, U., Gasparini, F., Sauter, A., Reymann, K.G., Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage (2000) Neuropharmacology, 39, pp. 911-917

Herrero, I., Miras-Portugal, M.T., Sánchez-Prieto, J., Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors (1998) J. Biol. Chem., 273, pp. 1951-1958

Jantzie, L.L., Talos, D.M., Selip, D.B., An, L., Jackson, M.C., Folkerth, R.D., Deng, W., Jensen, F.E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12

Kinon, B.J., Zhang, L., Millen, B.A., Osuntokun, O.O., Williams, J.E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group

Kohara, A., Takahashi, M., Yatsugi, S., Tamura, S., Shitaka, Y., Hayashibe, S., Kawabata, S., Okada, M., Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models (2008) Brain Res., 1191, pp. 168-179

Koller, M., Urwyler, S., Novel N-methyl-d-aspartate receptor antagonists: A review of compounds patented since 2006 (2010) Exp. Opin. Ther. Pat., 20, pp. 1683-1702

Koo, S.J., Pfaff, S.L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826

Lam, A.G., Soriano, M.A., Monn, J.A., Schoepp, D.D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123

Landucci, E., Boscia, F., Gerace, E., Scartabelli, T., Cozzi, A., Moroni, F., Mannaioni, G., Pellegrini-Giampietro, D.E., Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia (2009) Int. Rev. Neurobiol., 85, pp. 337-350

Landucci, E., Scartabelli, T., Gerace, E., Moroni, F., Pellegrini-Giampietro, D.E., CB1 receptors and post-ischemic brain damage: Studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices (2011) Neuropharmacology, 60, pp. 674-682

Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132

Lipton, P., Ischemic cell death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568

Lipton, S.A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170

Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J., Cotman, C.W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955

Maj, M., Bruno, V., Dragic, Z., Yamamoto, R., Battaglia, G., Inderbitzin, W., Stoehr, N., Flor, P.J., (-)-PHCCC, a positive allosteric modulator of mGluR4: Characterization, mechanism of action, and neuroprotection (2003) Neuropharmacology., 45, pp. 895-906

Makarewicz, D., Duszczyk, M., Gadamski, R., Danysz, W., Łazarewicz, J.W., Neuroprotective potential of group i metabotropic glutamate receptor antagonists in two ischemic models (2006) Neurochem. Int., 48, pp. 485-490

Mannaioni, G., Marino, M.J., Valenti, O., Traynelis, S.F., Conn, P.J., Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function (2001) J. Neurosci., 21, pp. 5925-5934

Marino, M.J., Williams, Jr.D.L., O'Brien, J.A., Valenti, O., McDonald, T.P., Clements, M.K., Wang, R., Conn, P.J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673

Masilamoni, G.J., Bogenpohl, J.W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J.R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073

Meldrum, B., Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission (1990) Cerebrovasc. Brain Metab. Rev., 2, pp. 27-57

Meli, E., Picca, R., Attucci, S., Cozzi, A., Peruginelli, F., Moroni, F., Pellegrini-Giampietro, D.E., Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo (2002) Pharmacol. Biochem. Behav., 73, pp. 439-446

Mermelstein, P.G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262

Micevych, P.E., Mermelstein, P.G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77

Miller, S., Sehati, N., Romano, C., Cotman, C.W., Exposure of astrocytes to thrombin reduces levels of the metabotropic glutamate receptor mGluR5 (1996) J. Neurochem., 67, pp. 1435-1447

Moroni, F., Attucci, S., Cozzi, A., Meli, E., Picca, R., Scheideler, M.A., Pellicciari, R., Pellegrini-Giampietro, D.E., The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death (2002) Neuropharmacology, 42, pp. 741-751

Moyanova, S.G., Mastroiacovo, F., Kortenska, L.V., Mitreva, R.G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R.T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118

Murotomi, K., Takagi, N., Takayanagi, G., Ono, M., Takeo, S., Tanonaka, K., MGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia (2008) J. Neurochem., 105, pp. 1625-1634

Nicoletti, F., Bockaert, J., Collingridge, G.L., Conn, P.J., Ferraguti, F., Schoepp, D.D., Wroblewski, J.T., Pin, J.P., Metabotropic glutamate receptors: From the workbench to the bedside 2011 (2011) Neuropharmacology, 60, pp. 1017-1041

Niswender, C.M., Johnson, K.A., Weaver, C.D., Jones, C.K., Xiang, Z., Luo, Q., Rodriguez, A.L., Conn, P.J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358

Niswender, C.M., Conn, P.J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322

Olney, J.W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359

Olney, J.W., Wozniak, D.F., Farber, N.B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240

Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Schoepp, D.D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107

Pisani, A., Gubellini, P., Bonsi, P., Conquet, F., Picconi, B., Centonze, D., Bernardi, G., Calabresi, P., Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons (2001) Neuroscience, 106, pp. 579-587

Price, D.L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020

Pshenichkin, S., Dolińska, M., Klauzińska, M., Luchenko, V., Grajkowska, E., Wroblewski, J.T., Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - Possible role as a dependence receptor (2008) Neuropharmacology, 55, pp. 500-508

Pshenichkin, S., Emery A., .C., Takoudjou G., .R., Diraddo, J., Hathaway, H., Grajkowska, E., Wroblewski J., .T., Neuroprotective and neurotoxic signaling of mGlu1 receptors (2011) Current Neuropharmacology., 9 (S1), p. 54

Rong, R., Ahn, J.Y., Huang, H., Nagata, E., Kalman, D., Kapp, J.A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161

Rossi, D., Brambilla, L., Valori, C.F., Roncoroni, C., Crugnola, A., Yokota, T., Bredesen, D.E., Volterra, A., Focal degeneration of astrocytes in amyotrophic lateral sclerosis (2008) Cell Death Differ., 15, pp. 1691-1700

Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111

Rothstein, J.D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359

Schober, A., Peterziel, H., Von Bartheld, C.S., Simon, H., Krieglstein, K., Unsicker, K., GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action (2007) Neurobiol. Dis., 25, pp. 378-391

Schoepp, D.D., Jane, D.E., Monn, J.A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476

Siesjö, B.K., Katsura, K., Kristián, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52

Slevin, J.T., Gerhardt, G.A., Smith, C.D., Gash, D.M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222

Spampinato, S.F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M.A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta}-amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20

Taylor, D.L., Diemel, L.T., Pocock, J.M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160

Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Wyss-Coray, T., Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology (2006) J. Clin. Invest., 116, pp. 3060-3069

Thomas, A.G., Liu, W., Olkowski, J.L., Tang, Z., Lin, Q., Lu, X.C., Slusher, B.S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40

Thomsen, C., Bruno, V., Nicoletti, F., Marinozzi, M., Pellicciari, R., (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors (1996) Mol. Pharmacol., 50, pp. 6-9

Tu, J.C., Xiao, B., Yuan, J.P., Lanahan, A.A., Leoffert, K., Li, M., Linden, D.J., Worley, P.F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726

Valenti, O., Marino, M.J., Wittmann, M., Lis, E., Dilella, A.G., Kinney, G.G., Conn, P.J., Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse (2003) J. Neurosci., 23, pp. 7218-7226

Werner, C.G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D.E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604

Xu, W., Wong, T.P., Chery, N., Gaertner, T., Wang, Y.T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412

Yoshioka, H., Sugita, M., Kinouchi, H., Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia (2009) Neurosci. Lett., 461, pp. 266-270

Zhou, M., Xu, W., Liao, G., Bi, X., Baudry, M., Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation (2009) Exp. Neurol., 218, pp. 75-82

Zipfel, G.J., Lee, J.M., Choi, D.W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544

Albers, G. W., Goldberg, M. P., Choi, D. W., N-methyl-d-aspartate antagonists: Ready for clinical trial in brain ischemia? (1989) Ann. Neurol., 125, pp. 398-40

Armentero, M. T., Fancellu, R., Nappi, G., Bramanti, P., Blandini, F., Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease (2006) Neurobiol. Dis., 22, pp. 1-9

Attucci, S., Carl, V., Mannaioni, G., Moroni, F., Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges (2001) Br. J. Pharmacol., 132, pp. 799-806

Bal zs, R., Miller, S., Romano, C., De Vries, A., Chun, Y., Cotman, C. W., Metabotropic glutamate receptor mGluR5 in astrocytes: Pharmacological properties and agonist regulation (1997) J. Neurochem., 69, pp. 151-163

Black, Y. D., Xiao, D., Pellegrino, D., Kachroo, A., Brownell, A. L., Schwarzschild, M. A., Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease (2010) Neurosci. Lett., 486, pp. 161-165

Bond, A., Jones, N. M., Hicks, C. A., Whiffin, G. M., Ward, M. A., O'Neill, M. F., Kingston, A. E., O'Neill, M. J., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo (2000) J. Pharmacol. Exp. Ther., 294, pp. 800-809

Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., Worley, P. F., Homer: A protein that selectively binds metabotropic glutamate receptors (1997) Nature, 386, pp. 284-288

Brazil, D. P., Hemmings, B. A., Ten years of protein kinase B signalling: A hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-664

Choi, D. W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634

Conn, P. J., Battaglia, G., Marino, M. J., Nicoletti, F., Metabotropic glutamate receptors in the basal ganglia motor circuit (2005) Nat. Rev. Neurosci., 6, pp. 787-798

De Vry, J., Horv th, E., Schreiber, R., Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu (1) receptor antagonist BAY 36-7620 (2001) Eur. J. Pharmacol., 428, pp. 203-214

Doherty, A. J., Palmer, M. J., Henley, J. M., Collingridge, G. L., Jane, D. E., (RS) -2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus (1997) Neuropharmacology, 36, pp. 265-267

Emery, A. C., Pshenichkin, S., Takoudjou, G. R., Grajkowska, E., Wolfe, B. B., Wroblewski, J. T., The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, -Arrestin-1-dependent ERK Phosphorylation (2010) J. Biol. Chem., 285, pp. 26041-26048

Emery A., . C., Hathaway, H., Pshenichkin, S., Takoudjou G., . R., Diraddo, J., Grajkowska, E., Yasuda R., . P., Wroblewski J., . T., Ligand bias at mGlu1 receptors reveals a second binding site at new endogenous agonists (2011) Curr. Neuropharmacol., 9 (S1), p. 18

Engers, D. W., Field, J. R., Le, U., Zhou, Y., Bolinger, J. D., Zamorano, R., Blobaum, A. L., Hopkins, C. R., Discovery, synthesis, and structure-activity relationship development of a series of N- (4-acetamido) phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu (4)) with CNS exposure in rats (2011) J. Med. Chem., 54, pp. 1106-1110

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Heywood, P., Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease (2003) Nat. Med., 9, pp. 589-595

Hardingham, G. E., Bading, H., Synaptic versus extra synaptic NMDA receptor signalling: Implications for neurodegenerative disorders (2010) Nat. Rev. Neurosci., 11, pp. 682-696

Jantzie, L. L., Talos, D. M., Selip, D. B., An, L., Jackson, M. C., Folkerth, R. D., Deng, W., Jensen, F. E., Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia (2011) Neuron Glia Biol., 14, pp. 1-12

Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Jarkova, N., A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia (2011) J. Clin. Psychopharmacol., 31, pp. 349-355. , the HBBI Study Group

Koo, S. J., Pfaff, S. L., Fine-tuning motor neuron properties: Signaling from the periphery (2002) Neuron, 35, pp. 823-826

Lam, A. G., Soriano, M. A., Monn, J. A., Schoepp, D. D., Lodge, D., McCulloch, J., Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia (1998) Neurosci. Lett., 254, pp. 121-123

Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132

Lipton, S. A., Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond (2006) Nat. Rev. Drug Discov., 5, pp. 160-170

Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., Cotman, C. W., Apoptosis is induced by beta-amyloid in cultured central nervous system neurons (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7951-7955

Marino, M. J., Williams, Jr. D. L., O'Brien, J. A., Valenti, O., McDonald, T. P., Clements, M. K., Wang, R., Conn, P. J., Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 13668-13673

Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K., Tamagnan, G., Votaw, J. R., Wichmann, T., Smith, Y., Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys (2011) Brain, 134, pp. 2057-2073

Mermelstein, P. G., Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors (2009) J. Neuroendocrinol., 21, pp. 257-262

Micevych, P. E., Mermelstein, P. G., Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain (2008) Mol. Neurobiol., 38, pp. 66-77

Moyanova, S. G., Mastroiacovo, F., Kortenska, L. V., Mitreva, R. G., Fardone, E., Santolini, I., Sobrado, M., Ngomba, R. T., Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage (2011) J. Cereb. Blood Flow Metab., 31, pp. 1107-1118

Niswender, C. M., Johnson, K. A., Weaver, C. D., Jones, C. K., Xiang, Z., Luo, Q., Rodriguez, A. L., Conn, P. J., Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4 (2008) Mol. Pharmacol., 74, pp. 1345-1358

Niswender, C. M., Conn, P. J., Metabotropic glutamate receptors: Physiology, pharmacology, and disease (2010) Annu. Rev. Pharmacol. Toxicol., 50, pp. 295-322

Olney, J. W., The toxic effects of glutamate and related compounds in the retina and the brain (1982) Retina, 2, pp. 341-359

Olney, J. W., Wozniak, D. F., Farber, N. B., Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies (1997) Arch. Neurol., 54, pp. 1234-1240

Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Schoepp, D. D., Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial (2007) Nat. Med., 13, pp. 1102-1107

Price, D. L., Rockenstein, E., Ubhi, K., Phung, V., MacLean-Lewis, N., Askay, D., Cartier, A., Masliah, E., Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-implications for excitotoxicity (2010) PLoS One, 5, p. 14020

Rong, R., Ahn, J. Y., Huang, H., Nagata, E., Kalman, D., Kapp, J. A., Tu, J., Ye, K., PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis (2003) Nat. Neurosci., 6, pp. 1153-1161

Rothman, S. M., Olney, J. W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111

Rothstein, J. D., 1995-1996. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis Clin. Neurosci., 3, pp. 348-359

Schoepp, D. D., Jane, D. E., Monn, J. A., Pharmacological agents acting at subtypes of metabotropic glutamate receptors (1999) Neuropharmacology, 38, pp. 1431-1476

Siesj, B. K., Katsura, K., Kristi n, T., The biochemical basis of cerebral ischemic damage (1995) J. Neurosurg. Anesthesiol., 7, pp. 47-52

Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R., Young, B., Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor (2005) J. Neurosurg., 102, pp. 216-222

Spampinato, S. F., Molinaro, G., Merlo, S., Iacovelli, L., Caraci, F., Battaglia, G., Nicoletti, F., Sortino, M. A., Estrogen receptors and type-1 metabotropic glutamate receptors are interdependent in protecting cortical Neurons against {beta} -amyloid toxicity (2012) Mol. Pharmacol., 81, pp. 12-20

Taylor, D. L., Diemel, L. T., Pocock, J. M., Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity (2003) J. Neurosci., 23, pp. 2150-2160

Thomas, A. G., Liu, W., Olkowski, J. L., Tang, Z., Lin, Q., Lu, X. C., Slusher, B. S., Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta (2001) Eur. J. Pharmacol., 430, pp. 33-40

Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., Worley, P. F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726

Werner, C. G., Scartabelli, T., Pancani, T., Landucci, E., Moroni, F., Pellegrini-Giampietro, D. E., Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance (2007) Eur. J. Neurosci., 25, pp. 3597-3604

Xu, W., Wong, T. P., Chery, N., Gaertner, T., Wang, Y. T., Baudry, M., Calpain-mediated mGluR1alpha truncation: A key step in excitotoxicity (2007) Neuron, 53, pp. 399-412

Zipfel, G. J., Lee, J. M., Choi, D. W., Reducing calcium overload in the ischemic brain (1999) N. Engl. J Med., 341, pp. 1543-1544



Moving from early studies, we here review the most recent evidence linking metabotropic glutamate (mGlu) receptors to processes of neurodegeneration/ neuroprotection. The use of knockout mice and subtype-selective drugs has increased our knowledge of the precise role played by individual mGlu receptor subtypes in these processes. Activation of mGlu1 and mGlu5 receptors may either amplify or reduce neuronal damage depending on the context and the nature of the toxic insults. In contrast, mGlu1 and mGlu5 receptors antagonists are consistently protective in in vitro and in vivo models of neuronal death. A series of studies suggest that mGlu1 receptor antagonists or negative allosteric modulators (NAMs) are promising candidates for the treatment of ischemic brain damage, whereas mGlu5 receptor NAMs, which have been clinically developed for the treatment of Parkinson's disease (PD) and l-DOPA-induced dyskinesias, protect nigro-striatal dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) toxicity in mice and monkeys. Activation of glial mGlu3 receptors promotes the formation of various neurotrophic factors, such as transforming growth factor-β (TGF-β), glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF). Hence, selective mGlu3 receptor agonists or positive allosteric modulators (PAMs) (not yet available) are potentially helpful in the treatment of chronic neurodegenerative disorders such as PD, Alzheimer's disease (AD), and amyotrophic lateral sclerosis. Selective mGlu2 receptor PAMs should be used with caution in AD patients because these drugs are shown to amplify β-amyloid neurotoxicity. Finally, mGlu4 receptor agonists/PAMs share with mGlu5 receptor NAMs the ability to improve motor symptoms associated with PD and attenuate nigro-striatal degeneration at the same time. No data are yet available on the role of mGlu7 and mGlu8 receptors in neurodegeneration/ neuroprotection. © 2012 Elsevier Ltd. All rights reserved.
Nessun risultato.
Nessun risultato.

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Spampinato SF, Copani A, Nicoletti F, Sortino MA, Caraci F
* Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? (13 visite)
Frontiers In Molecular Neuroscience (ISSN: 1662-5099, 1662-5099linking), 2018 Nov 13; 11: 414-414.
Impact Factor: 3.902
Dettagli    Esporta in BibTeX    Esporta in EndNote

Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G
* Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (44 visite)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Impact Factor: 8.29
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (61 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressèns P, Cannella M, Caraci F, Copani A, Bruno V, Battaglia G, Conn PJ, Nicoletti F
* Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system (75 visite)
Neuropharm (ISSN: 0028-3908linking, 1873-7064electronic), 2018 Jan; 128: 301-313.
Impact Factor: 3.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (68 visite)
Curr Opin Pharmacol (ISSN: 1471-4973electronic, 1471-4892linking), 2017 Dec 23; 38: 1-7.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sciacca MFM, Romanucci V, Zarrelli A, Monaco I, Lolicato F, Spinella N, Galati C, Grasso G, D'Urso L, Romeo M, Diomede L, Salmona M, Bongiorno C, Di Fabio G, La Rosa C, Milardi D
* Inhibition of Abeta Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry (91 visite) (PDF 94 visite)
Acs Chem Neurosci (ISSN: 1948-7193electronic, 1948-7193linking), 2017 Jun 09; N/D: N/D-N/D.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Copani A
* The underexplored question of beta-amyloid monomers (61 visite)
Eur J Pharmacol (ISSN: 1879-0712electronic, 0014-2999linking), 2017 May 31; N/D: N/D-N/D.
Impact Factor: 2.896
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Rosa LD, Vigliotti C, Cataldi M
* VEGF mimic peptides: Potential applications in central nervous system therapeutics (4 visite)
New Horizons Transl Med (ISSN: 2307-5023), 2017; 3(5): 233-251.
Impact Factor:
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Tascedda F, Merlo F, Benatti C, Spampinato S, Munafò A, Leggio GM, Nicoletti F, Brunello N, Drago F, Sortino MA, Copani A
* Fluoxetine Prevents Ab1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth- Factor-b1 (77 visite) (PDF 110 visite)
Frontiers In Pharmacology, 2016 Oct; 7: 1-11.
Impact Factor: 4.418
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Bruno V, Copani A, Matrisciano F, Nicoletti F, Battaglia G
* The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders (76 visite)
Neuropharm (ISSN: 1873-7064electronic, 0028-3908linking), 2016 Apr 30; N/D: N/D-N/D.
Impact Factor: 5.012
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pignataro G, Ziaco B, Tortiglione A, Gala R, Cuomo O, Vinciguerra A, Lapi D, Mastantuono T, Anzilotti S, D'Andrea LD, Pedone C, Di Renzo G, Annunziato L, Cataldi M
* Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion (114 visite)
Acs Chem Neurosci (ISSN: 1948-7193electronic, 1948-7193linking), 2015 Sep 16; 6(9): 1517-1525.
Impact Factor: 4.348
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Pappalardo G, Basile L, Giuffrida A, Copani A, Tosto R, Sinopoli A, Giuffrida ML, Pirrone E, Drago F, Pignatello R, Guccione S
* Neuroprotective effects of the monoamine oxidase inhibitor Tranylcypromine and its amide derivatives against Abeta(1-42)-induced toxicity (176 visite)
Eur J Pharmacol (ISSN: 1879-0712electronic, 0014-2999linking), 2015 Jul 7; 764: 256-263.
Impact Factor: 2.73
Dettagli    Esporta in BibTeX    Esporta in EndNote

Peluso S, De Rosa A, Antenora A, Lieto M, Criscuolo C, Barbieri F, Pappata S, De Michele G
* Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage (75 visite)
Parkinsonism Relat Disord (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2015 Feb; 21(2): 156-158.
Impact Factor: 3.794
Dettagli    Esporta in BibTeX    Esporta in EndNote

Travaglia A, Pietropaolo A, Di Martino R, Nicoletti VG, La Mendola D, Calissano P, Rizzarelli E
* A Small Linear Peptide Encompassing the NGF N-Terminus Partly Mimics the Biological Activities of the Entire Neurotrophin in PC12 Cells (133 visite)
Acs Chem Neurosci (ISSN: 1948-7193, 1948-7193electronic, 1948-7193linking), 2015; 6(8): 1379-1392.
Impact Factor: 4.348
Dettagli    Esporta in BibTeX    Esporta in EndNote

Moccia M, Erro R, Montella S, Carotenuto A, Pappata S, Orefice G
* Diagnostic challenges of Parkinsonism occurring in multiple sclerosis (77 visite)
Acta Neurol Belg (ISSN: 0300-9009), 2014 Oct 12; 115(3): 513-515.
Impact Factor: 0.894
Dettagli    Esporta in BibTeX    Esporta in EndNote

Doti N, Reuther C, Scognamiglio PL, Dolga AM, Plesnila N, Ruvo M, Culmsee C
* Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress (146 visite)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2014 Jan 16; 5(1): e993-e993.
Impact Factor: 5.014
Dettagli    Esporta in BibTeX    Esporta in EndNote

Forte G, Travaglia A, Magrì A, Satriano C, La Mendola D
* Adsorption of NGF and BDNF derived peptides on gold surfaces (176 visite)
Phys Chem Chem Phys (ISSN: 1463-9076, 1463-3907, 1463-9084electronic), 2014; 16(4): 1536-1544.
Impact Factor: 4.493
Dettagli    Esporta in BibTeX    Esporta in EndNote

Travaglia A, La Mendola D, Magrì A, Pietropaolo A, Nicoletti VG, Grasso G, Malgieri G, Fattorusso R, Isernia C, Rizzarelli E
* Zinc(II) interactions with brain-derived neurotrophic factor N-terminal peptide fragments: inorganic features and biological perspectives (150 visite)
Inorg Chem (ISSN: 1520-510x, 0020-1669, 1520-510xelectronic), 2013 Oct 7; 52(19): 11075-11083.
Impact Factor: 4.794
Dettagli    Esporta in BibTeX    Esporta in EndNote

Quadri M, Fang M, Picillo M, Olgiati S, Breedveld Gj Graafland J, Wu B, Xu F, Erro R, Amboni M, Pappata S, Quarantelli M, Annesi G, Quattrone A, Chien Hf Barbosa ER, International Parkinsonism Genetics Network Oostra Ba Barone P, Wang J, Bonifati V
* Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism (130 visite)
Hum Mutat (ISSN: 1059-7794, 1098-1004, 1098-1004electronic), 2013 Sep; 34(9): 1208-1215.
Impact Factor: 5.122
Dettagli    Esporta in BibTeX    Esporta in EndNote

McNeill A, Wu RM, Tzen KY, Aguiar PC, Arbelo JM, Barone P, Bhatia K, Barsottini O, Bonifati V, Bostantjopoulou S, Bressan R, Cossu G, Cortelli P, Felicio A, Ferraz HB, Herrera J, Houlden H, Hoexter M, Isla C, Lees A, Lorenzo-Betancor O, Mencacci NE, Pastor P, Pappata S, Pellecchia MT, Silveria-Moriyama L, Varrone A, Foltynie T, Schapira AH
* Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis (133 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013 Jul 23; 8(7): e69190-e69190.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Erro R, Pappata S, Picillo M, Rocco M, Santangelo G, Barone P, Vitale C
* Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism (92 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2013 Mar 26; 80(13): e147-e147.
Impact Factor: 8.303
Dettagli    Esporta in BibTeX    Esporta in EndNote

Travaglia A, La Mendola D, Magrì A, Nicoletti VG, Pietropaolo A, Rizzarelli E
* Copper, BDNF and Its N-terminal domain: inorganic features and biological perspectives (134 visite)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2012 Dec 3; 18(49): 15618-15631.
Impact Factor: 5.831
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, Cuzzocrea S, Rizzarelli E, Calabrese EJ
* Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity (171 visite)
Biochim Biophys Acta (ISSN: 0006-3002, 0925-4439, 1570-9639), 2012 May; 1822(5): 753-783.
Impact Factor: 3.733
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cirillo G, Colangelo AM, Bianco MR, Cavaliere C, Zaccaro L, Sarmientos P, Alberghina L, Papa M
* BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury (108 visite)
Biotechnology Advances (ISSN: 0734-9750), 2012 Jan; 30(1): 223-232.
Impact Factor: 9.599
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (234 visite)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G
* CaMK4 gene deletion induces hypertension (105 visite)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D.
Impact Factor: 2.882
Dettagli    Esporta in BibTeX    Esporta in EndNote

Castellano I, Merlino A
* γ-glutamyltranspeptidases: Sequence, structure, biochemical properties, and biotechnological applications (108 visite)
Cell Mol Life Sci (ISSN: 1420-682x), 2012; 69(20): 3381-3394.
Impact Factor: 5.615
Dettagli    Esporta in BibTeX    Esporta in EndNote

Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G
* The relationship between cerebral vascular disease and parkinsonism: The VADO study (154 visite)
Parkinsonism Relat Disord (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780.
Impact Factor: 3.274
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Rosa A, Rinaldi C, Tucci T, Pappata S, Rossi F, Morra VB, Faggiano A, Colao A, De Michele G
* Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding? (136 visite)
Parkinsonism Relat Disord (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2011 Dec; 17(10): 771-773.
Impact Factor: 3.795
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (209 visite)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bellia F, Vecchio G, Cuzzocrea S, Calabrese V, Rizzarelli E
* Neuroprotective features of carnosine in oxidative driven diseases (132 visite)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 258-266.
Impact Factor: 9.97
Dettagli    Esporta in BibTeX    Esporta in EndNote

Erro R, Amboni M, Vitale C, Longo K, Rocco M, Russo C, Pappata S, Brunetti A, Barone P
* The "eye of the tiger" sign in pure akinesia with gait freezing (90 visite) (PDF 117 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478), 2011 Sep; 32(4): 703-705.
Impact Factor: 1.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Striano P, Caranci F, Pappata S, Zara F, Striano S
* Hemidystonia in uncontrolled type 2 diabetes mellitus (52 visite)
Arch Neurol (ISSN: 1538-3687electronic, 0003-9942linking), 2011 May; 68(5): 674-675.
Impact Factor: 7.584
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cirillo G, Bianco MR, Colangelo AM, Cavaliere C, Daniele DL, Zaccaro L, Alberghina L, Papa M
* Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor (122 visite)
Neurobiology Of Disease (ISSN: 0969-9961), 2011 Mar; 41(3): 630-639.
Impact Factor: 5.403
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (267 visite)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dinacci D, Tessitore A, Russo AA, De Bonis ML, Lavorgna L, Picconi O, Sacco R, Bonavita S, Gallo A, Servillo G, Marcuccio L, Comerci M, Galletti P, Alfano B, Tedeschi G
* BDNF Val66Met polymorphism and brain volumes in multiple sclerosis (181 visite) (PDF 132 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Feb; 32(1): 117-123.
Impact Factor: 1.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro L, Breedveld GJ, Manganelli F, Iodice R, Pisciotta C, Nolano M, Punzo F, Quarantelli M, Pappata S, Di Fonzo A, Oostra BA, Bonifati V
* Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability (85 visite)
Neurogenetics (ISSN: 1364-6745, 1364-6753, 1364-6753electronic), 2011 Feb; 12(1): 33-39.
Impact Factor: 3.354
Dettagli    Esporta in BibTeX    Esporta in EndNote

Spina-Purrello V, Giliberto S, Barresi V, Nicoletti VG, Giuffrida Stella AM, Rizzarelli E
* Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFγ-induced oxidative stress (136 visite)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2010 Dec; 35(12): 2144-2153.
Impact Factor: 2.608
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A
* The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology (143 visite)
Rev Neurosci (ISSN: 0334-1763), 2010; 21(2): 83-93.
Impact Factor: 2.047
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Nagren K, Darcourt J, Tatsch K, Van Laere KJ
* EANM procedure guideline for brain perfusion SPECT using Tc-99m-labelled radiopharmaceuticals, version (165 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Dec; 36(12): 2093-2102.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA
* Nitric oxide in cell survival: a janus molecule (130 visite)
Antioxid Redox Signal (ISSN: 1557-7716, 1523-0864), 2009 Nov; 11(11): 2717-2739.
Impact Factor: 7.581
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Cornelius C, Mancuso C, Barone E, Calafato S, Bates T, Rizzarelli E, Kostova AT
* Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases (158 visite)
Frontiers In Bioscience (ISSN: 1093-4715, 1093-9946), 2009 Jan 1; 14: 376-397.
Impact Factor: 3.736
Dettagli    Esporta in BibTeX    Esporta in EndNote

Chiechio S, Zammataro M, Morales ME, Busceti CL, Drago F, Th Gereau RW, Copani A, Nicoletti F
* Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain (109 visite)
Mol Pharmacol (ISSN: 0026-895x), 2009; 75(5): 1014-1020.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E
* Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity (297 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2008 Dec; 33(12): 2444-2471.
Impact Factor: 2.26
Dettagli    Esporta in BibTeX    Esporta in EndNote

Castiglione M, Calafiore M, Costa L, Sortino MA, Nicoletti F, Copani A
* Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice (97 visite)
Neuropharm (ISSN: 0028-3908, 1873-7064electronic, 0028-3908linking), 2008 Sep; 55(4): 560-567.
Impact Factor: 3.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gustavsson T, Banyasz A, Sarkar N, Markovitsi D, Improta R
* Statin: New life for an old drug (128 visite)
Pharmacol Res Academic Press, 2008 Jun 23; 350(1-3): 1-2.
Impact Factor: 3.976
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Battaglia G, Busceti C, Biagioni F, Mastroiacovo F, Bosco P, Drago F, Nicoletti F, Sortino MA, Copani A
* TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway (110 visite)
Neurobiology Of Disease (ISSN: 0969-9961), 2008 May; 30(2): 234-242.
Impact Factor: 4.852
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colangelo AM, Bianco MR, Vitagliano L, Cavaliere C, Cirillo G, De Gioia L, Diana D, Colombo D, Redaelli C, Zaccaro L, Morelli G, Papa M, Sarmientos P, Alberghina L, Martegani E
* A New Nerve Growth Factor (ngf)-Mimetic Peptide Active On Neuropathic Pain In Rats (146 visite)
J Neurosci (ISSN: 0270-6474, 0270-0647, 1529-2401), 2008 Mar 12; 28(11): 2698-2709.
Impact Factor: 7.452
Dettagli    Esporta in BibTeX    Esporta in EndNote

Copani A, Guccione S, Giurato L, Caraci F, Calafiore M, Sortino MA
* The cell cycle molecules behind neurodegeneration in Alzheimer's disease: Perspectives for drug development (128 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2008; 15(24): 2420-2432.
Impact Factor: 4.823
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (224 visite)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nicoletti VG, Santoro AM, Grasso G, Vagliasindi LI, Giuffrida ML, Cuppari C, Purrello VS, Stella AMG, Rizzarelli E
* Carnosine interaction with nitric oxide and astroglial cell protection (251 visite)
Journal Of Neuroscience Research (ISSN: 0360-4012), 2007 Sep 1; 85(10): 2239-2245.
Impact Factor: 3.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Rosa A, Carducci C, Antonozzi I, Giovanniello T, Xhoxhi E, Criscuolo C, Menchise V, Striano S, Filla A, De Michele G
* A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia [9] (112 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2007 Sep; 254(8): 1133-1134.
Impact Factor: 2.477
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pappata S
* Tracking the dynamics of secondary degeneration after stroke (98 visite)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 2007 Jun; 78(6): 554-554.
Impact Factor: 3.857
Dettagli    Esporta in BibTeX    Esporta in EndNote

Chiechio S, Copani A, Gereau R, Nicoletti F
* Acetyl-l-carnitine in neuropathic pain (80 visite)
Cns Drugs (ISSN: 1172-7047), 2007; 21: 38-38.
Impact Factor: 4.514
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore E, Varrone A, Sansone V, Nolano M, Bruni AC, De Rosa A, Santoro L, Pappata S, Filla A, De Michele G
* Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 (101 visite)
Mov Disord (ISSN: 0885-3185, 1531-8257), 2006 Jun; 21(6): 872-875.
Impact Factor: 3.323
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (107 visite)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Colombrita C, Guagliano E, Sapienza M, Ravagna A, Cardile V, Scapagnini G, Santoro AM, Mangiameli A, Butterfield DA, Giuffrida Stella AM, Rizzarelli E
* Protective effect of carnosine during nitrosative stress in astroglial cell cultures (108 visite)
Neurochemical Research (ISSN: 0364-3190, 1573-6903), 2005 Jun; 30(6-7): 797-807.
Impact Factor: 2.187
Dettagli    Esporta in BibTeX    Esporta in EndNote

Filippo C, Mariangela C, Giuseppina F, Pier Luigi C, Angelo B, Marco C, Giuseppe B, Paolo B, Ferdinando N, Agata C, Maria Angela S
* Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity (249 visite)
Brain Res (ISSN: 0006-8993), 2005; 1047(1): 30-37.
Impact Factor: 2.296
Dettagli    Esporta in BibTeX    Esporta in EndNote

Miletich RS, Bankiewicz KS, Quarantelli M, Plunkett RJ, Frank J, Kopin IJ, Di Chiro G
MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys (87 visite)
Ann Neurol (ISSN: 0364-5134), 1994 Jun; 35(6): 689-697.
Impact Factor: 9.513
Dettagli    Esporta in BibTeX    Esporta in EndNote

Miletich RS, Quarantelli M, Di Chiro G
REGIONAL CEREBRAL BLOOD-FLOW IMAGING WITH TC-99M-BICISATE SPECT IN ASYMMETRIC PARKINSONS-DISEASE - STUDIES WITH AND WITHOUT CHRONIC DRUG-THERAPY (104 visite)
Journal Of Cerebral Blood Flow And Metabolism (ISSN: 0271-678x), 1994 Jan; 14: S106-S106.
Impact Factor: 5.836
Dettagli    Esporta in BibTeX    Esporta in EndNote



60 Records (54 escludendo Abstract e Conferenze).
Impact factor totale: 280.173 (249.115 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 270.339 (239.12 escludendo Abstract e Conferenze).







    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Bruno Alfano in data Thursday 12 March 2015, 9:45:16
153 visite. Ultima visita in data Friday 28 December 2018, 4:54:32

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Friday 15 February 2019, 13:06:47